1073TiP A phase I, first-in-human, multicenter, open-label, dose-escalation study of IPH5201 as monotherapy or in combination with durvalumab ± oleclumab in advanced solid tumours
2020
-
Correction
-
Source
-
Cite
-
Save
0
References
1
Citations
NaN
KQI